Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshay Sharma

Showing results (231-240 of 326) with videos related to

Pageof 33
Sort By:
British Journal of Haematology|June 23, 2022
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell diseaseAkshay Sharma, Alexis Leonard, Kamille West, et al.
Transplantation and Cellular Therapy|February 12, 2023
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice GuidelinesEllen Fraint, Hisham Abdel-Azim, Neel S Bhatt, et al.
Transplantation and Cellular Therapy|October 10, 2025
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research AnalysisNosha Farhadfar, Stephanie Bo-Subait, Gabrielle Schmidt, et al.
Cytotherapy|March 20, 2023
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantMoises Garcia-Rosa, Allistair Abraham, Alice Bertaina, et al.
Transplantation and Cellular Therapy|February 13, 2022
Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric PatientsRebecca Epperly, Aimee C Talleur, Ying Li, et al.
Journal of Infection and Public Health|January 7, 2019
Variations in macrophage migration inhibitory factor gene are not associated with visceral leishmaniasis in IndiaAnshuman Mishra, Pandarisamy Sundaravadivel, Sunil Kumar Tripathi, et al.
Blood Advances|May 6, 2021
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell diseaseAlexis Leonard, Akshay Sharma, Naoya Uchida, et al.
Transplantation and Cellular Therapy|May 23, 2023
Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant CentersAkshay Sharma, Brent Logan, Noel Estrada-Merly, et al.
Bone Marrow Transplantation|November 28, 2022
Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AMLThomas Pfeiffer, Ying Li, Emily Ashcraft, et al.
Haematologica|October 15, 2020
Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixaforNaoya Uchida, Alexis Leonard, David Stroncek, et al.
Pageof 33

Showing results (231-240 of 326) with videos related to

Sort By:
Pageof 33
British Journal of Haematology|June 23, 2022
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell diseaseAkshay Sharma, Alexis Leonard, Kamille West, et al.
Transplantation and Cellular Therapy|February 12, 2023
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice GuidelinesEllen Fraint, Hisham Abdel-Azim, Neel S Bhatt, et al.
Transplantation and Cellular Therapy|October 10, 2025
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research AnalysisNosha Farhadfar, Stephanie Bo-Subait, Gabrielle Schmidt, et al.
Cytotherapy|March 20, 2023
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantMoises Garcia-Rosa, Allistair Abraham, Alice Bertaina, et al.
Transplantation and Cellular Therapy|February 13, 2022
Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric PatientsRebecca Epperly, Aimee C Talleur, Ying Li, et al.
Journal of Infection and Public Health|January 7, 2019
Variations in macrophage migration inhibitory factor gene are not associated with visceral leishmaniasis in IndiaAnshuman Mishra, Pandarisamy Sundaravadivel, Sunil Kumar Tripathi, et al.
Blood Advances|May 6, 2021
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell diseaseAlexis Leonard, Akshay Sharma, Naoya Uchida, et al.
Transplantation and Cellular Therapy|May 23, 2023
Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant CentersAkshay Sharma, Brent Logan, Noel Estrada-Merly, et al.
Bone Marrow Transplantation|November 28, 2022
Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AMLThomas Pfeiffer, Ying Li, Emily Ashcraft, et al.
Haematologica|October 15, 2020
Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixaforNaoya Uchida, Alexis Leonard, David Stroncek, et al.
Pageof 33